Qualifying conditions with specific criteria: While a prescriber might accept your report of high blood pressure, insurance may require documented blood pressure readings above certain thresholds, or evidence of treatment with specific medications
For the first time, the 2026 ADA Standards of Care guidelines suggests that physicians may consider GLP-1 medications in selected patients with type 1 diabetes and obesity
these effects diminish after discontinuation
Nguyen NH, et al
A Two-Way ANOVA was used to confirm significant effects of ambulatory activity, horizontal activity, vertical activity, total distance travelled, and total rest time
* * * To learn more about the obesity opportunity, please read our obesity deep dive, part of our recent white paper on the broader renaissance of cardiometabolic innovation